Table 1.
Yeasta |
Humanb,c | Mouseb | ||||||
---|---|---|---|---|---|---|---|---|
δexo+ |
δexo− |
η |
η | η | ||||
RPA/RFC/PCNA | − | + | − | + | − | + | − | − |
Bypass (%)d | ||||||||
3′-CCGATT | 8.9 | 25 | 4.8 | 24 | 47 | 54 | 24 | 17 |
3′-CCGoATT | 1.3 | 4.1 | 1.5 | 5.9 | 62 | 69 | 36 | 31 |
Relative bypass (%) | 15 | 16 | 31 | 25 | 130 | 130 | 150 | 180 |
Switch | No | No | No | No | Yes | Yes | No | No |
Bypass (%) | ||||||||
3′-TTGGG | 71 | 75 | 34 | 23 | ||||
3′-TTGoGG | 18 | 23 | 86 | 57 | ||||
Relative bypass (%) | 25 | 31 | 250 | 250 | ||||
Switch | No | No | Yes | Yes |
aEfficiency measurements made using 70-mer template with streptavidin blocked ends (see ‘Materials and Methods’ section).
bEfficiency measurements made using 45-mer template (see ‘Materials and Methods’ section).
cBypass efficiency measured in three other template sequence contexts was 3′ … CGoATC … = 220%; 3′- … CAGoTC … = 180%; 3′- … CAGoTT … = 180%.
dExperiments depicted in Figures 1 and 2 were quantified and the bypass amount on each template calculated as previously described (39,41). Relative bypass is the amount of 8-oxoG bypass compared to undamaged DNA. Switch is defined as a change from lower to higher termination probability when comparing values at the 8-oxoG and next undamaged base.